Skip to content

PAR PHARMACEUTICAL COMPANIES, INC.

CIK 0000878088

← back to feed
Revenue (TTM)
$1.32B
−8.2% YoY Q2 Aug 2015
Net Income (TTM)
−$38.84M
−304.2% YoY Q2 Aug 2015
EPS Diluted (TTM)
$1.44
+135.0% YoY Q2 Aug 2015
Gross Margin
39.2%
Q2 Aug 2015
Operating Margin
4.3%
Q2 Aug 2015
Net Margin
-2.9%
Q2 Aug 2015
Free Cash Flow (TTM)
$192.19M
Q2 Aug 2015
Cash
$154.85M
Q2 Aug 2015
Total Debt
$2.33B
Q2 Aug 2015
Shares Outstanding
100 sh
Q2 Aug 2015

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings